Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
HOLY SMOLY.....JUST RELEASE NEWS!!
IDEH..............WOW!http://latestbusiness-news.com/ideh-to-exploit-the-parking-management-market-aims-to-be-the-next-big-leader-in-this-space-112962.html
BUYING MORE {IDEH} SWEET BREAKOUT!
IM BUYING MORE $$$$$$$$$$$
____________ IDEH________________
WOW
STRONG BUY
IDEH volume is HUGE!!!!!!! READY TO RUN PEOPLE
(IDEH) BREAKOUT ON NEWS TODAY!
$$$$$$$$$$$$$ IDEH BREAKOUT! $$$$$$$$$$$$$$$
NEWS!
THIS IS ABOUT TO RUN $$$$$$$$$$
SAEI JUST HAD A THIRD BID!
LOL,BID BACKED BY RUSSIAN FAMILYS?
SCAMMMMMMMMMMMMMMMMMMMMMMMMM!
BEWARE PEOPLE!
NEWS OUT ON $$$ APCVZ $$$
Good luck people!
NEWS OUT ON $$$$ APCVZ $$$$ OUT!
Good luck to longs!
Can't sit in front of a computer all day like most here!
Missed a lot of tops,by the time I get home from work its sold off before I could.
Never does this garbage hold a gain.
So when I take my leave for surgery,ill have time to dump this garbage at the right price once and for all,believe that!
Provided is does not go BANKRUPT.
Bravada/muscleflex has been the worst stock i've ever owned in my life.
The volume is pathetic,everyday.
There's more talk about this comapany,then the stock moves(big bark and without a bite).
Millions of other penny stock with way better volume,and more constant movement,another words,traders do not care to trade this stock.I mean fund traders, not us.
The Kardasians
TLK Fusion
The Complete Package
The Sugar-Free Show(LOL. Remember That )? Old timers
The Beagle
The Buddy
The clothing line with KRIS KARDASIAN for men?
Dick Clark Productions? On the complete package website.LOL!
WHAT'S NEXT?
LULU COMING IN TO BUYOUT A NEW UPSCALE WOMEN'S CLOTHING COMPANY CALLED BRAVADA.
Stay tuned people,financials were released last week on time,you see danny caught a lot of flack for allowing a couple of prior Q reports be late,i'm happy to see he hired a new accountant.
All good news that we have such a transparent CEO thats looking out for my best interest as a brav shareholder.IMO
BUYING MORE $$$$$$ 0.0027 $$$$$$$$$
FROM YAHOO BOARD:
APP Pharmaceuticals receives FDA approval for the drug doxorubicon
Dec 11,2010 09:57:13 EST
Microspheres for delivery of doxorubicin. The clinical trial will involve U.S. and international interventional radiologists who treat patients with localized, unresectable hepatocellular carcinoma. The FDA action will result in the first phase 3 study in the U.S. comparing drug-eluting microspheres to conventional chemoembolization in the treatment of hepatocellular carcinoma. Currently in the U.S. there is no FDA-approved embolic for the treatment of liver cancer
Link?
IF EVERYBODY HERE,STOPPED,LOOKED AT (APCVZ) AND THE NEWS PENDING
AND WE ALL BOUGHT 15000 TO 20000 SHARES,BRUSH FIRE!!!!!!!!!
HOWEVER HAS ENOUGH BALLS,TO BUY $$$ APCVZ $$$
WITH SOME REAL CASH,I'LL MATCH E'M
YOU DON'T KNOW ME BUT I'M ASKING TO TRUST ME
WE WILL BE REWARDED
BUY ALL YOU CAN,ITS ABOUT TO BREAKOUT.IMO
HEADS UP PEOPLE,SOMETHING COOKING BIGTIME IN (APCVZ)!
BUYOUT IN THE WORKS...IMO
VOLUME STRANGE BEHAVIOR IN VOLUME
$$$$$$$$$$$ APCVZ $$$$$$$$$$$$
LOCKED AND LOADED!
LONG TIME COMING
IMO,BUYOUT FOR (APCVZ)ABOUT TO HAPPEN ON HIGH VOLUME ANY HOUR
APRROVAL OF THE DRUG TODAY,AND NEWS PENDING.
APCVZ IS A LOT HIGHER VOLUME THAN THE NORMAL.
DRUG TREATMENT APPROVED TODAY!
IMO,BUYOUT
Post # of 364730
APCVZ DRUG APPROVED $$$$$$$$$$$ BREAKOUT $$$$$$$$$$$$ READ!
Pharmaceuticals, Inc. On Friday Dec 10 2010, 1:08 am EST
SCHAUMBURG, Ill.--(BUSINESS WIRE)-- APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., (NASDAQ:APCVZ - News) announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to market Topotecan for Injection, and plans to launch immediately.
Topotecan for Injection is therapeutically equivalent to the reference-listed drug Hycamtin®, which is currently marketed by the innovator GlaxoSmithKline, plc. According to IMS data, U.S. sales of Hycamtin®, in 2009 were $157.1million 1.
Topotecan for Injection is indicated for small cell lung cancer sensitive disease after failure of first-line chemotherapy, and is also indicated for use in combination therapy with Cisplatin for stage IV-B, and for recurrent, or persistent carcinoma of the cervix not amenable to curative treatment with surgery and/or radiation therapy. APP will market Topotecan for Injection in 4 mg single dose vials; the product is bar-coded and preservative
APCVZ DRUG APPROVED $$$$$$$$$$$ BREAKOUT $$$$$$$$$$$$ READ!
Pharmaceuticals, Inc. On Friday Dec 10 2010, 1:08 am EST
SCHAUMBURG, Ill.--(BUSINESS WIRE)-- APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., (NASDAQ:APCVZ - News) announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to market Topotecan for Injection, and plans to launch immediately.
Topotecan for Injection is therapeutically equivalent to the reference-listed drug Hycamtin®, which is currently marketed by the innovator GlaxoSmithKline, plc. According to IMS data, U.S. sales of Hycamtin®, in 2009 were $157.1million 1.
Topotecan for Injection is indicated for small cell lung cancer sensitive disease after failure of first-line chemotherapy, and is also indicated for use in combination therapy with Cisplatin for stage IV-B, and for recurrent, or persistent carcinoma of the cervix not amenable to curative treatment with surgery and/or radiation therapy. APP will market Topotecan for Injection in 4 mg single dose vials; the product is bar-coded and preservative-free.
APCVZ DRUG APPROVED $$$$$$$$$ BREAKING NEWS $$$$$$$$$$$$$$
BUY ********** APCVZ ***********
volume is spiking
ready for a run!
APCVZ VOLUME PICKING UP,COULD BE THAT TIME
TAKE A PEAK!
FOLLOW THE NEWS TO THE MONEY {ACTC} READ THIS!
Advanced Cell Technology's CEO is bullish about company's advancements
Advanced Cell Technology’s CEO is bullish about company's advancements
Dec. 10, 2010 (Baystreet.ca) --
Several key announcements have pushed Advanced Cell Technology’s (OTCBB:ACTC) stock from just under a nickel in late November to an intraday high of $.20 during Wednesday’s session and volume has made it apparent that a growing crowd of day traders momentum players have now joined biotech investors in cheering on the small biotech.
The excitement around ACTC comes after a recent series of key positive announcements including the fact that the FDA granted orphan drug status to the micro-cap's patented embryonic stem cell derived treatment for specific forms of Macular Degeneration and blindness (Stargardt's Macular Dystrophy and Dry Age-related Macular Degeneration). The eye conditions destroy the pigmented layer of retina (retinal pigment epithelium) which is the pigmented cell layer just outside the neurosensory retina that nourishes retinal visual cells.
Advanced Cell Technology has shown success introducing the embryonic stem cell derived RPE cells into the eye in animal models and this resulted in 100% improvement with no side effects for more than 220 days. Human clinical trials are expected to start in the first quarter of 2011, and could potentially take only a few weeks to show positive results according to some analysts.
In addition, for only the second time in history (following Geron’s therapy for spinal cord injury), the FDA granted approval for clinical trials for a therapy derived from human embryonic stem cells.
BioMedReports: It appears that suddenly your company has a lot of attention given your news developments. What do you make of all the activity in your stock during recent days?
We anticipate the climb will continue for the upcoming days and weeks ahead.
We believe a price target will soon be announced and look forward in reaching that milestone for investors who help make this possible.
FOLLOW THIS NEWS TO THE MONEY (ACTC) READ!
Advanced Cell Technology's CEO is bullish about company's advancements
Advanced Cell Technology’s CEO is bullish about company's advancements
Dec. 10, 2010 (Baystreet.ca) --
Several key announcements have pushed Advanced Cell Technology’s (OTCBB:ACTC) stock from just under a nickel in late November to an intraday high of $.20 during Wednesday’s session and volume has made it apparent that a growing crowd of day traders momentum players have now joined biotech investors in cheering on the small biotech.
The excitement around ACTC comes after a recent series of key positive announcements including the fact that the FDA granted orphan drug status to the micro-cap's patented embryonic stem cell derived treatment for specific forms of Macular Degeneration and blindness (Stargardt's Macular Dystrophy and Dry Age-related Macular Degeneration). The eye conditions destroy the pigmented layer of retina (retinal pigment epithelium) which is the pigmented cell layer just outside the neurosensory retina that nourishes retinal visual cells.
Advanced Cell Technology has shown success introducing the embryonic stem cell derived RPE cells into the eye in animal models and this resulted in 100% improvement with no side effects for more than 220 days. Human clinical trials are expected to start in the first quarter of 2011, and could potentially take only a few weeks to show positive results according to some analysts.
In addition, for only the second time in history (following Geron’s therapy for spinal cord injury), the FDA granted approval for clinical trials for a therapy derived from human embryonic stem cells.
BioMedReports: It appears that suddenly your company has a lot of attention given your news developments. What do you make of all the activity in your stock during recent days?
We anticipate the climb will continue for the upcoming days and weeks ahead.
We believe a price target will soon be announced and look forward in reaching that milestone for investors who help make this possible.
$$$$$$$$$$$ ACTC IS ABOUT TO JINGLE $$$$$$$$$$$$$
More bullish news,the uptrend charts look AMAZING
Strong buy!
$$$$$$$$$ ACTC BREAKOUT $$$$$$$$$$
Heading north again on more bullish news!
STRONG BUY NOW. IMO
I agree,
Let's talk about financials,being late,again!
Let's talk about the fact that volume dropped off a cliff in the last 5 months
Let's talk about why we are a 52 week lows' in the PPS.
Let's talk about what happened to "the complete package"
Let's talk about why no word from Danny Alex,too busy maybe?
Let's talk about how some of us feel left in the dark with accounts reading RED!
That's the meat and potatoes,for topics on this bravada company IMO!
I don't think so
Why so secretive?
SHORTS!
We are heading north,lONGS
LOL
News leaking of phase2 results?
Anyone see this on aria blogs?
wow
(ACTC) OMG! 10 BAGGER?
HOLY COW!
$$$$$$$$ ACTC $$$$$$$$$$$$$$$$
HOLY SMOLY!!!!!!!
$$$$$$$$$$ ACTC $$$$$$$$$$$$ WOW!
Volume amazing
Strap on the trading shoes tommorow!
Good Lord' Look At The Momentum Building In $$$ ACTC $$$
Volume amazing
Tommorow means strap your trading boots on!
LOOK AT THE MOMENTUM BUILDING IN $$$ ACTC $$$
Holy smokes,volume amazing
Tommorow is going to be huge